Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study seeks new treatments for oral cancer in dogs
The team aims to identify the biological markers that show whether the cancer is likely to spread.

Findings could lead to better outcomes for canine patients.

Vets at the University of Edinburgh are seeking new treatments for canine oral malignant melanoma.

One of the most common types of mouth cancer affecting dogs, it hoped the identification of new drugs could enhance the outcome for patients diagnosed with this devastating disease.

Building on previous research, the study will see scientists from the University’s Hospital for Small Animals, the Roslin Institute and the MRC Human Genetics Unit at the Institute of Genetics and Cancer, study cancerous tissue samples from laboratories from across the globe. 

The team will identify the biological markers that show whether the cancer is likely to spread and grow tissue samples from diseased cells in the laboratory from which to test new treatments.

Dr Kelly Blacklock, a senior lecturer in small animal soft tissue surgery, said: “There is much to discover about the development of canine oral melanoma, for example how it may differ between breeds, its impact on various tissues or location within the mouth. 

“Identifying sub-types of this disease can help to inform our understanding how spread progresses, so that more effective potential drug targets, tailored to a sub-type, if necessary, can be identified.”

Funded by the Kennel Club Charitable Trust, scientists hope the study will make way for more personalised, precision canine medicine.The team also hopes to build a living biobank of organoids derived from dog tissue as a platform for screening drugs to prevent cancer spread. 

Reverend Bill King, chairman of The Kennel Club Charitable Trust, said: “We are proud to be supporting this important research, which could change lives of thousands of dogs in the future. More personalised medicine can bring better results, helping to stop the spread and save canine lives. 

“It is important more is invested in research like this to better understand canine diseases and give us better tools to fight them, and I am looking forward to learning about the findings of this research.”

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.